NEW · Life Sciences Tools & Services
DHR
Danaher Corp · $150.48B
214.06
+1.09%
Price
251 sessions shownTechnicals
from daily closesRSI · 14 day
61.9
Avg true range · 14d
2.83%
Volatility · 20d annualised
28.7%
Trend · 20d vs 50d
Up
vs 20-day average
0.23%
vs 50-day average
2.52%
vs 200-day average
6.18%
200-day average
201.60
Internals
where it sits, and how hard it is being traded52-week low
160.93
52-week high
242.80
Volume vs its 20-day avg
0.91×
Beta vs the market
0.79
Sitting 65% of the way up its 52-week range (160.93 → 242.80)
Swings
prices it actually turned at — highest or lowest of the surrounding 11 sessionsTurned down · Jul 28
209.90
Turned down · Aug 10
209.37
Turned down · Aug 20
220.67
Turned up · Jul 21
165.75
Turned up · Aug 18
199.49
Turned up · Sep 14
199.09
Fundamentals
P/E
37.58
Fwd P/E
—
P/S
5.99
P/B
3.08
EV/EBITDA
29.27
ROE
7.7%
ROA
4.7%
Gross margin
58.6%
Net margin
—
Debt / equity
0.35
Rev growth
4.6%
EPS growth
-19.8%
Every figure here is measured from live market data as of Oct 4, 05:03 PM. Nothing is estimated or filled in — where a figure shows — the source had no value for it, and a section you don’t see had no data at all. This describes what the market has already done. It is not a forecast, and not financial advice.